pentoxifylline has been researched along with Allergic Bronchopulmonary Mycosis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline (PTX) has been shown to competitively inhibit the family 18 chitinases in fungi, which may be an new antifungal therapy." | 1.62 | Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice. ( Feng, C; Li, C; Zhang, J; Zhang, M; Zhang, S; Zhou, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, C | 1 |
| Zhang, M | 1 |
| Zhang, S | 1 |
| Zhang, J | 1 |
| Li, C | 1 |
| Zhou, J | 1 |
1 other study available for pentoxifylline and Allergic Bronchopulmonary Mycosis
| Article | Year |
|---|---|
Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Chitinases; Disease | 2021 |